Given that TET cases with higher IRL scores may not be suitable for immunotherapy, it is necessary to explore several potentially effective drugs to target the prognosis-related IRLs (AC004466.3, AC138207.2, AC148477.2, AL450270.1, HOXB-AS1 and SNHG8). Here, HOXB-AS1 is linked to thymic epithelial neoplasm.